Research Library

Over half of all Americans live in a state where cannabis is legalized. And yet, the federal government has not reclassified marijuana since 1970. According to the Controlled Substances Act, it is considered a “Schedule 1” substance — the same classification as heroin and crack cocaine with no accepted medical use.

An overview of the ABA's Cannabis Law & Policy Committee, which is composed of attorneys across North America who have various mainstream practices and who seek to be stewards of historic changes in the pioneering field of marijuana law.

Products containing hemp extracts high in CBD are gaining mainstream popularity, acceptance and federal legality. In this article, Lisa Pittman, nonresident fellow in drug policy, focuses on litigation issues particular to hemp.

According to the authors, as a leading agricultural state, Texas is poised to become the new leader in hemp production, whether for medicinal or industrial purposes.

According to the authors, developments in cannabis law, arbitration clause interpretation and the economic loss doctrine show that numerous facets of business litigation are changing rapidly.